Np mrd loader

Record Information
Version2.0
Created at2022-09-04 03:40:29 UTC
Updated at2022-09-04 03:40:29 UTC
NP-MRD IDNP0187496
Secondary Accession NumbersNone
Natural Product Identification
Common Name(1r,3r,6r,8s,10r,11s,12r,13s,16s,17r)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione
DescriptionGinkgolide B belongs to the class of organic compounds known as ginkgolides and bilobalides. These are diterpene lactones with a structure based either on the gingkolide or the bilobalide skeleton. The ginkgolide skeleton is a very rigid structure consisting of hexacyclic C20 trilactone. The cis-fused F/A/D/C ring junction forms an empty semi-ball hole, the D ring contains a cage form tetrahydrofuran ring which occupies the center of the empty hole, and the oxygen atoms of the D,C and F ring and 10-hydroxyl group consist of an analogous crown ether structure. (1r,3r,6r,8s,10r,11s,12r,13s,16s,17r)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione is found in Ginkgo biloba. (1r,3r,6r,8s,10r,11s,12r,13s,16s,17r)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0¹,¹¹.0³,⁷.0⁷,¹¹.0¹³,¹⁷]nonadecane-5,15,18-trione was first documented in 2021 (PMID: 34944919). Based on a literature review a significant number of articles have been published on Ginkgolide B (PMID: 35276465) (PMID: 35343157) (PMID: 36044079) (PMID: 36015354) (PMID: 35948139) (PMID: 35922794).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC20H24O10
Average Mass424.4020 Da
Monoisotopic Mass424.13695 Da
IUPAC NameNot Available
Traditional NameNot Available
CAS Registry NumberNot Available
SMILES
C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@]34[C@H]5C[C@@H](C(C)(C)C)C33[C@@H](O)C(=O)O[C@H]3O[C@@]4(C(=O)O5)[C@@]12O
InChI Identifier
InChI=1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9+,10+,11+,15+,17?,18-,19-,20-/m1/s1
InChI KeySQOJOAFXDQDRGF-AFUSRUNCSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Ginkgo bilobaLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as ginkgolides and bilobalides. These are diterpene lactones with a structure based either on the gingkolide or the bilobalide skeleton. The ginkgolide skeleton is a very rigid structure consisting of hexacyclic C20 trilactone. The cis-fused F/A/D/C ring junction forms an empty semi-ball hole, the D ring contains a cage form tetrahydrofuran ring which occupies the center of the empty hole, and the oxygen atoms of the D,C and F ring and 10-hydroxyl group consist of an analogous crown ether structure.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassPrenol lipids
Sub ClassTerpene lactones
Direct ParentGinkgolides and bilobalides
Alternative Parents
Substituents
  • Ginkgolide-skeleton
  • Diterpenoid
  • Tricarboxylic acid or derivatives
  • Furofuran
  • Gamma butyrolactone
  • Tetrahydrofuran
  • Tertiary alcohol
  • Cyclic alcohol
  • Secondary alcohol
  • Lactone
  • Carboxylic acid ester
  • Oxacycle
  • Organoheterocyclic compound
  • Polyol
  • Carboxylic acid derivative
  • Acetal
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Carbonyl group
  • Alcohol
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00035830
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkGinkgolide
METLIN IDNot Available
PubChem Compound138404401
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Liang H, Yuan X, Sun C, Sun Y, Yang M, Feng S, Yao J, Liu Z, Zhang G, Li F: Preparation of a new component group of Ginkgo biloba leaves and investigation of the antihypertensive effects in spontaneously hypertensive rats. Biomed Pharmacother. 2022 May;149:112805. doi: 10.1016/j.biopha.2022.112805. Epub 2022 Mar 8. [PubMed:35276465 ]
  2. He YQ, Zong CH, Wang J, Li Q, Wang J, Wu YJ, Chen Y, Liu XS: [Application of near infrared spectroscopy to predict contents of various lactones in chromatographic process of Ginkgo Folium]. Zhongguo Zhong Yao Za Zhi. 2022 Mar;47(5):1293-1299. doi: 10.19540/j.cnki.cjcmm.20211206.202. [PubMed:35343157 ]
  3. Samandar F, Tehranizadeh ZA, Saberi MR, Chamani J: CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN). J Mol Model. 2022 Aug 31;28(9):283. doi: 10.1007/s00894-022-05284-8. [PubMed:36044079 ]
  4. Wang Q, Ma R, Liu P, Cheng G, Yang Q, Chen X, Wu Z, Yuan D, Chen T: Efficient Sustained-Release Nanoparticle Delivery System Protects Nigral Neurons in a Toxin Model of Parkinson's Disease. Pharmaceutics. 2022 Aug 18;14(8):1731. doi: 10.3390/pharmaceutics14081731. [PubMed:36015354 ]
  5. Zhang J, Cheng J, Yan L, Yu Y, Hao C, Zhao A, Chen S, Liu A: Discovery of unreported ginkgolides of anti-PAF activity using characteristic ion and neutral loss recognition strategy in Ginkgo biloba L. Phytochemistry. 2022 Nov;203:113355. doi: 10.1016/j.phytochem.2022.113355. Epub 2022 Aug 7. [PubMed:35948139 ]
  6. Briskey D, Rao A: A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome. BMC Complement Med Ther. 2022 Aug 3;22(1):206. doi: 10.1186/s12906-022-03679-x. [PubMed:35922794 ]
  7. Luo T, Hao YN, Lin DD, Huang X, Wu AS: Ginkgolide B improved postoperative cognitive dysfunction by inhibiting microgliosis-mediated neuroinflammation in the hippocampus of mice. BMC Anesthesiol. 2022 Jul 18;22(1):229. doi: 10.1186/s12871-022-01750-1. [PubMed:35850641 ]
  8. Cao Y, Yang L, Cheng H: Ginkgolide B Protects Against Ischemic Stroke via Targeting AMPK/PINK1. Front Pharmacol. 2022 Jun 28;13:941094. doi: 10.3389/fphar.2022.941094. eCollection 2022. [PubMed:35837278 ]
  9. Jahan S, Redhu NS, Siddiqui AJ, Iqbal D, Khan J, Banawas S, Alaidarous M, Alshehri B, Mir SA, Adnan M, Pant AB: Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach. Pharmaceutics. 2022 May 25;14(6):1123. doi: 10.3390/pharmaceutics14061123. [PubMed:35745697 ]
  10. Wang L, Xia K, Han L, Zhang M, Fan J, Song L, Liao A, Wang W, Guo J: Local Administration of Ginkgolide B Using a Hyaluronan-Based Hydrogel Improves Wound Healing in Diabetic Mice. Front Bioeng Biotechnol. 2022 May 25;10:898231. doi: 10.3389/fbioe.2022.898231. eCollection 2022. [PubMed:35694224 ]
  11. Zhang X, Diao X, Li L, Zhang Y, Liao M, Zhang G, Zhang L: Identification of metabolites of Ginkgolide B in vivo and in vitro using ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. J Sep Sci. 2022 Jul;45(14):2458-2477. doi: 10.1002/jssc.202101016. Epub 2022 May 18. [PubMed:35543088 ]
  12. Zhu J, Jin Z, Yang L, Zhao C, Hu J, Chen J, Han Y, Yu P, Luo J, Kong L, Zhang C: Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice. Pharmacol Res. 2022 Jun;180:106240. doi: 10.1016/j.phrs.2022.106240. Epub 2022 May 2. [PubMed:35513225 ]
  13. Zhao H, Guo Q, Li B, Shi M: The Efficacy and Safety of Ginkgo Terpene Lactone Preparations in the Treatment of Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol. 2022 Mar 18;13:821937. doi: 10.3389/fphar.2022.821937. eCollection 2022. [PubMed:35392576 ]
  14. Cai D, Luo Z, Su J, Gan H, Wang Z, Liu X, Li S, Wu J, Chen J, Ma R, Huang M, Zhong G: Exposure-Response Analysis and Mechanism of Ginkgolide B's Neuroprotective Effect in Acute Cerebral Ischemia/Reperfusion Stage in Rat. Biol Pharm Bull. 2022;45(4):409-420. doi: 10.1248/bpb.b21-00781. [PubMed:35370265 ]
  15. Authors unspecified: Statement of Retraction: Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29. Cell Cycle. 2022 Apr;21(7):757. doi: 10.1080/15384101.2021.2014708. Epub 2022 Feb 22. [PubMed:35191821 ]
  16. Zhu T, Wang L, Wang LP, Wan Q: Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: Applications for natural compounds from medicinal herbs. Biomed Pharmacother. 2022 Apr;148:112719. doi: 10.1016/j.biopha.2022.112719. Epub 2022 Feb 12. [PubMed:35168073 ]
  17. Shao L, Dong C, Geng D, He Q, Shi Y: Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer's disease. Metab Brain Dis. 2022 Feb;37(2):329-341. doi: 10.1007/s11011-021-00886-2. Epub 2022 Jan 20. [PubMed:35050445 ]
  18. Kawasaki K, Kasamatsu A, Ando T, Saito T, Nobuchi T, Nozaki R, Iyoda M, Uzawa K: Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway. Cancers (Basel). 2021 Dec 15;13(24):6299. doi: 10.3390/cancers13246299. [PubMed:34944919 ]
  19. LOTUS database [Link]